Skip to content

XIV International HIV Drug Resistance Workshop: preventing mother-to-child transmission

Sexual transmission of HCV found in Swiss HIV-positive gay men

Two generic versions of nevirapine approved for PEPFAR use

Duration of ddI treatment and dose risk factors for CD4 loss in patients taking ddI/tenofovir

Lipid-lowering drugs better at lowering blood fats caused by protease inhibitors than switching to NNRTI

Once daily Kaletra: dose escalation rarely the answer for those with low plasma levels

Cotrimoxazole prophylaxis for people with HIV reduces illness and death in other family members too

Lipid-lowering drugs more effective than switch to NNRTI in managing lipid elevations

Replacement of protease inhibitor results in improved blood fat levels, but doesn't stop fat loss